World's Best Scientists 2026 revealed!
Jacques Cadranel

Jacques Cadranel

D-Index & Metrics

Medicine

D-Index
93
Citations
33847
World Ranking
10833
National Ranking
334

Overview

Jacques Cadranel is affiliated with Université Paris Cité in France and has a substantial body of research primarily focused on pulmonary and respiratory medicine. Their work spans several subfields, including pathology and forensic medicine, epidemiology, physiology, and rheumatology. The scientist's research covers a variety of medical topics, with particular emphasis on interstitial lung diseases and idiopathic pulmonary fibrosis, systemic sclerosis and related diseases, inflammatory myopathies and dermatomyositis, eosinophilic disorders and syndromes, sarcoidosis and beryllium toxicity research, medical imaging and pathology studies, and the long-term effects of COVID-19.

Cadranel has contributed to the scientific literature through publications in numerous peer-reviewed journals. Frequent publication venues include:

  • Revue des Maladies Respiratoires Actualités
  • La Revue de Médecine Interne
  • Revue des Maladies Respiratoires
  • European Respiratory Journal
  • Annals of the Rheumatic Diseases

Notable recent papers authored or coauthored by Cadranel include:

  • The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements, 2020, The Lancet Rheumatology
  • Different phenotypes in dermatomyositis associated with anti-MDA5 antibody, 2020, Neurology
  • Methotrexate and rheumatoid arthritis associated interstitial lung disease, 2020, European Respiratory Journal
  • Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial, 2023, European Respiratory Journal
  • Predictors of mortality in fibrosing pulmonary sarcoidosis, 2020, Respiratory Medicine

Frequent collaborators in Cadranel's research efforts include:

  • Hilario Nunès
  • Raphaël Borie
  • Vincent Cottin
  • Pierre-Yves Brillet
  • Bruno Crestani

The volume of publications, especially in pulmonary and respiratory medicine, reflects a focused engagement with diseases affecting the lungs and associated systemic conditions. The topics of interest and coauthorship network suggest multidisciplinary collaboration across related medical fields. Publications span clinical trials, consensus statements, and observational studies, underscoring a blend of evidence-based approaches and clinical research.

Best Publications

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

    Vincent A. Miller;Vincent A. Miller;Vera Hirsh;Jacques Cadranel;Yuh Min Chen

  • Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

    Marie-Caroline Dieu-Nosjean;Martine Antoine;Claire Danel;Didier Heudes

  • Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

    David W. Denning;Jacques Cadranel;Catherine Beigelman-Aubry;Florence Ader

  • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Aryeh Fischer;Katerina M. Antoniou;Kevin K. Brown;Jacques Cadranel

  • Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

    Fabrice Barlesi;Julien Mazieres;Jean-Philippe Merlio;Didier Debieuvre

  • Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

    Marguerite Guiguet;François Boué;Jacques Cadranel;Jean-Marie Lang

  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

    Marina Chiara Garassino;Jennifer G. Whisenant;Li Ching Huang;Annalisa Trama

  • Primary pulmonary lymphoma

    J Cadranel;M Wislez;M Antoine

  • Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.

    Eric Oksenhendler;Monica Duarte;Jean Soulier;Patrice Cacoub

  • Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

    Arnaud Scherpereel;Julien Mazieres;Laurent Greillier;Sylvie Lantuejoul

  • Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients

    Magid Herida;Murielle Mary-Krause;Régis Kaphan;Jacques Cadranel

  • Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

    Myriam Delaunay;Jacques Cadranel;Amélie Lusque;Nicolas Meyer

  • Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

    Emmanuelle Boulanger;Laurence Gérard;Jean Gabarre;Jean-Michel Molina

  • Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer.

    D Fennell;Yvonne J Summers;J Cadranel;T Benepal

  • A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

    George R Blumenschein;E. F. Smit;D. Planchard;D. W. Kim

  • Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis

    V. Cottin;F. Thivolet-Bejui;M. Reynaud-Gaubert;J. Cadranel

  • Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

    Mehdi Touat;Thierry Maisonobe;Samuel Knauss;Omar Ben Hadj Salem

  • Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

    M. Beau-Faller;N. Prim;A.-M. Ruppert;I. Nanni-Metéllus

  • Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

    Dominique Lauque;Jacques Cadranel;Romain Lazor;Jacques Pourrat

Frequent Co-Authors

Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Julien Mazieres
Julien Mazieres Paul Sabatier University
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Nicolas Girard
Nicolas Girard Institute Curie
Jean-François Cordier
Jean-François Cordier Claude Bernard University Lyon 1
Benjamin Besse
Benjamin Besse University of Paris-Saclay
Benoit Wallaert
Benoit Wallaert Institut Pasteur
Eric Oksenhendler
Eric Oksenhendler Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the world of medicine in the USA opens up diverse online degree options and career directions beyond the traditional MD. For those interested in mental health, online psych np programs offer a flexible route to advanced practice nursing, enabling graduates to provide specialized psychiatric care.

If patient care isn’t your path, degrees in healthcare management may be appealing. Earning health administration degrees online can prepare you for roles in coordination, strategy, and leadership within healthcare institutions. For those comparing the financial aspects, understanding the cost of mha degree programs can help you choose an option that fits your budget and career goals.

Ambitious nursing professionals may also seek doctoral-level qualifications. The most affordable dnp programs can advance your expertise in clinical practice and leadership. These flexible online pathways allow you to tailor your education and carve out new career opportunities within the healthcare field.

Best Scientists Citing Jacques Cadranel

Trending Scientists

Recently Published Articles